Agilent's Dako Announces FDA Approval of New Test for Lung Cancer Patients, PD-L1 IHC 28-8 pharmD
October 12, 2015 at 04:26 AM EDT
Dako, an Agilent Technologies (NYSE: A) company and a worldwide provider of cancer diagnostics, announced Oct. 9 that the U.S. Food and ...
